News & Updates

Obesity med cessation more likely after RYGB than sleeve gastrectomy

15 Apr 2022 by

Patients who are on obesity-related medications before undergoing bariatric surgery may be more likely to discontinue their medications and less likely to restart them after undergoing Roux-en-Y gastric bypass (RYGB) than laparoscopic sleeve gastrectomy (LSG), a recent study has shown.

Obesity med cessation more likely after RYGB than sleeve gastrectomy

15 Apr 2022

Wild-type GIST: Who does it affect and where does it typically originate?

15 Apr 2022

Wild-type gastrointestinal stromal tumours (GIST), though rare, tend to develop more frequently in older adults and commonly originate in the stomach or small intestine, a recent study has found. Though treatment options are limited, surgical resection and systemic therapy remain the principal modalities.

Wild-type GIST: Who does it affect and where does it typically originate?

15 Apr 2022

In-store nutrition education enhances adherence to DASH diet

15 Apr 2022 by

Personalized nutrition advice conducted at grocery stores led to significant improvements in DASH* diet adherence, according to findings from the SuperWIN** trial.

In-store nutrition education enhances adherence to DASH diet

15 Apr 2022

GPs rank routine screening for AF as crucial as for cancers

15 Apr 2022 by

Screening for atrial fibrillation (AF) is considered to be as important as for common cancers and should be incorporated into other healthcare programmes such as flu vaccination and cancer screening programmes, based on data from the AFFECT-EU survey of GPs that was presented at EHRA 2022.

GPs rank routine screening for AF as crucial as for cancers

15 Apr 2022

Vupanorsen lowers lipids in statin-treated individuals with high cholesterol levels

15 Apr 2022

In the management of statin-treated patients with elevated cholesterol levels, the antisense oligonucleotide targeting angiopoietin-like protein 3 (ANGPTL3) vupanorsen reduces levels of nonhigh-density lipoprotein cholesterol (non-HDL-C) and other lipid parameters, according to the results of TRANSLATE-TIMI 70.

Vupanorsen lowers lipids in statin-treated individuals with high cholesterol levels

15 Apr 2022

Which symptoms contribute to severe visual field damage in glaucoma?

15 Apr 2022

Variance in visual field (VD) damage is substantially driven by five patient-reported symptoms, according to a cross-sectional study.

Which symptoms contribute to severe visual field damage in glaucoma?

15 Apr 2022

T(11;14) translocation not linked to worse outcomes in multiple myeloma

15 Apr 2022

In patients with multiple myeloma (MM), the chromosome translocation t(11;14) does not seem to be associated with worse prognosis, resulting in similar treatment outcomes as other standard-risk subgroups, reports a recent study.

T(11;14) translocation not linked to worse outcomes in multiple myeloma

15 Apr 2022

Add-on ixazomib yields survival gains in post-transplant myeloma

15 Apr 2022

The combination of lenalidomide plus ixazomib in the maintenance treatment of patients with post-transplant myeloma leads to better progression-free survival (PFS) compared with lenalidomide alone in historical controls, according to a study.

Add-on ixazomib yields survival gains in post-transplant myeloma

15 Apr 2022

Vupanorsen reduces non-HDL-C levels in adults with hyperlipidaemia already on statins

15 Apr 2022 by

Vupanorsen significantly reduces non–high-density lipoprotein cholesterol (non-HDL-C) levels in adults with hyperlipidaemia already taking statins, according to the TRANSLATE-TIMI 70* trial presented at ACC 2022.

Vupanorsen reduces non-HDL-C levels in adults with hyperlipidaemia already on statins

15 Apr 2022

Maintenance selinexor promising for PFS in advanced/recurrent endometrial cancer

14 Apr 2022 by

Maintenance treatment with selinexor improved progression-free survival (PFS) in patients with advanced or recurrent endometrial cancer who had previously received first-line chemotherapy, particularly those with endometrioid histology and wild-type p53, according to a study presented at SGO 2022.

Maintenance selinexor promising for PFS in advanced/recurrent endometrial cancer

14 Apr 2022

News & Updates

Filter by Specialty:

Specialty:

Obesity med cessation more likely after RYGB than sleeve gastrectomy

Obesity med cessation more likely after RYGB than sleeve gastrectomy

Wild-type GIST: Who does it affect and where does it typically originate?

Wild-type GIST: Who does it affect and where does it typically originate?

In-store nutrition education enhances adherence to DASH diet

In-store nutrition education enhances adherence to DASH diet

GPs rank routine screening for AF as crucial as for cancers

GPs rank routine screening for AF as crucial as for cancers

Vupanorsen lowers lipids in statin-treated individuals with high cholesterol levels

Vupanorsen lowers lipids in statin-treated individuals with high cholesterol levels

Which symptoms contribute to severe visual field damage in glaucoma?

Which symptoms contribute to severe visual field damage in glaucoma?

T(11;14) translocation not linked to worse outcomes in multiple myeloma

T(11;14) translocation not linked to worse outcomes in multiple myeloma

Add-on ixazomib yields survival gains in post-transplant myeloma

Add-on ixazomib yields survival gains in post-transplant myeloma

Vupanorsen reduces non-HDL-C levels in adults with hyperlipidaemia already on statins

Vupanorsen reduces non-HDL-C levels in adults with hyperlipidaemia already on statins

Maintenance selinexor promising for PFS in advanced/recurrent endometrial cancer

Maintenance selinexor promising for PFS in advanced/recurrent endometrial cancer